The Clinical Effect of Propranolol on Long QT Syndrome in 21 Patients

李翠兰,胡大一,刘文玲,李运田,商丽华,马志敏,李蕾
DOI: https://doi.org/10.3969/j.issn.1007-2659.2003.06.004
2003-01-01
Abstract:To observe the effects of propranolol,a β-blocker, on the long QT syndrome (LQTS), 21 long QT syndrome(LQTS) patients who were taken propranolol regularly were selected to study the effects of propranolol on the LQTS patients. Results: The mean age for patients were 24.4±12.4 years and age distribution for the first attack is 11.2±11.1. The dosage of propranolol was 63±44 mg/day or 1.3±0.7 mg/kg. During administration of propranolol , there were 8cases underwent left cardiac sympathetic denervation (LCSD), 1 case implanted with pacemaker, 1 case implanted with implantable cardioverter defibrillator(ICD), and 2 cases taken mexiletine. The QTc decreased from 570±70 to 500±60 ms ( P 0.0001) after 15.9±32.8 months follow-up. At the same time, the rest heart rate was not changed significantly. The syncope episodes in 19 of 21 patients who had syncope attack before treatment decreased from 1.90±1.72 to 0.17±0.40 times per year after long-term administration of propranolol, P =0.02. Conclusion:Propranolol could decrease the syncope episodes in most LQTS patients and shorten repolarization. However, for some patients, combined LCSD,pacemaker, or ICD may be needed.
What problem does this paper attempt to address?